Peter G Gibson
Gibson, Peter G.
Gibson, Peter.
Gibson, Peter, Dr.
VIAF ID: 231108670 (Personal)
Permalink: http://viaf.org/viaf/231108670
Preferred Forms
- 100 1 _ ‡a Gibson, Peter
- 100 1 _ ‡a Gibson, Peter
- 100 1 _ ‡a Gibson, Peter G.
-
- 100 1 _ ‡a Gibson, Peter G.
-
-
-
-
-
-
- 100 0 _ ‡a Peter G Gibson
4xx's: Alternate Name Forms (6)
5xx's: Related Names (3)
- 510 2 _ ‡a Nan jing da xue ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a University of New South Wales ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a University of Wollongong ‡b School of Mechanical, Materials & Mechatronic Engineering ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
1999 evidence-based review of the Australian Six Step Asthma Management Plan, c2000: | |
The asthmas : a precision medicine approach to treatable traits, diagnosis and management | |
Evidence-based respiratory medicine | |
Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites | |
Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. | |
Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD) | |
Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis | |
Inflammatory phenotypes in adult asthma: clinical applications | |
Inflammatory subtypes in asthma: assessment and identification using induced sputum | |
Inflammometry: the current state of play | |
Inflammometry to assess airway diseases. | |
Influence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPD | |
Influence of Maternal Body Mass Index and Macrophage Activation on Asthma Exacerbations in Pregnancy. | |
Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae | |
Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review. | |
Innate immune activation in neutrophilic asthma and bronchiectasis. | |
Innate immune mechanisms linking non-esterified fatty acids and respiratory disease. | |
Innate immune responses are increased in chronic obstructive pulmonary disease | |
Integrated health and education input in the development of educational resources about asthma for schools | |
The Integrins α3β1and α6β1 Physically and Functionally Associate with CD36 in Human Melanoma Cells | |
Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma | |
Interventions for educating children who are at risk of asthma-related emergency department attendance | |
Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings | |
Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis | |
Investigating the effects of arctic dietary intake on lung health | |
Involuntary glottal closure during inspiration in muscle tension dysphonia | |
Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? | |
Laryngeal Dysfunction: Assessment and Management for the Clinician. | |
Laryngeal sensory dysfunction in laryngeal hypersensitivity syndrome. | |
Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma | |
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid | |
Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma | |
Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. | |
Lycopene enrichment of cultured airway epithelial cells decreases the inflammation induced by rhinovirus infection and lipopolysaccharide. | |
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma | |
Macrophage activation, age and sex effects of immunometabolism in obese asthma. | |
Macrophage dysfunction in the pathogenesis and treatment of asthma. | |
Management of acute COPD exacerbations in Australia: do we follow the guidelines? | |
Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. | |
Management of chronic refractory cough | |
Managing Asthma in Pregnancy (MAP) trial: FeNO levels and childhood asthma. | |
Mannitol challenge for assessment of airway responsiveness, airway inflammation and inflammatory phenotype in asthma. | |
Maternal and neonatal outcomes of pregnancies complicated by asthma in an Australian population. | |
Maternal asthma is associated with reduced female fetal growth. | |
Maternal history of miscarriages and measures of fertility in relation to childhood asthma | |
Mechanisms of cough | |
Methotrexate as a steroid sparing agent for asthma in adults. | |
Microvascular effects of corticotropin-releasing hormone in human skin vary in relation to estrogen concentration during the menstrual cycle. | |
Monitoring asthma, 2005: | |
Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis. | |
Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense? | |
Multidisciplinary care in chronic airway diseases: the Newcastle model | |
Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. | |
Neutrophil extracellular traps are associated with inflammation in chronic airway disease. | |
Neutrophilic asthma is characterised by increased rhinosinusitis with sleep disturbance and GERD. | |
Neutrophilic asthma: welcome back! | |
Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. | |
Obese Asthmatics are Characterised by Altered Adipose Tissue Macrophage Activation. | |
Obesity and childhood asthma - mechanisms and manifestations. | |
Obesity in COPD: to treat or not to treat? | |
Observational study of mental health in asthmatic women during the prenatal and postnatal periods | |
Occupational exposures, smoking and airway inflammation in refractory asthma | |
Older peoples' perception of tests used in the assessment and management of COPD and asthma | |
Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study | |
Oxidative stress in cystic fibrosis: dietary and metabolic factors. | |
Oxidized vitamin E and glutathione as markers of clinical status in asthma. | |
PBB: definition, mechanisms, and treatment. | |
Peer-led asthma education for adolescents: impact evaluation | |
Perceptual voice characteristics in chronic cough and paradoxical vocal fold movement | |
Periostin levels and eosinophilic inflammation in poorly-controlled asthma | |
Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. | |
Persistence of rhinovirus RNA and IP-10 gene expression after acute asthma | |
Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children | |
Severe asthma |